N-Acetyl-L-Cysteine
Vaccine Adverse Reaction
Independent Medical AlliancePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
4 Active assets in the Vaccine Adverse Reaction cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ARG Independent Medical Alliance | Phase 2 | CCC |
L-Citrulline Independent Medical Alliance | Phase 2 | CCC |
Glutamine Independent Medical Alliance | Phase 2 | CCC |
L-Serine Independent Medical Alliance | Phase 2 | CCC |
Same molecule, other indications
N-Acetyl-L-Cysteine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →